Purpose: To compare the predictive roles of qualitative (PI-RADSv2) and quantitative assessment (ADC metrics), in differentiating Gleason pattern (GP) 3 + 4 from the more aggressive GP 4 + 3 prostate cancer (PCa) using radical prostatectomy (RP) specimen as the reference standard. Methods: We retrospectively identified treatment-naı¨ve peripheral (PZ) and transitional zone (TZ) Gleason Score 7 PCa patients who underwent multiparametric 3T prostate MRI (DWI with b value of 0,1400 and where unavailable, 0,500) and subsequent RP from 2011 to 2015. For each lesion identified on MRI, a PI-RADSv2 score was assigned by a radiologist blinded to pathology data. A PI-RADSv2 score £ 3 was defined as ''low risk,'' a PI-RADSv2 score ‡ 4 as ''high risk'' for clinically significant PCa. Mean tumor ADC (ADC T ), ADC of adjacent normal tissue (ADC N ), and ADC ratio (ADC T / ADC N ) were calculated. Stepwise regression analysis using tumor location, ADC T and ADC ratio , b value, low vs. high PI-RADSv2 score was performed to differentiate GP 3 + 4 from 4 + 3. Results: 119 out of 645 cases initially identified met eligibility requirements. 76 lesions were GP 3 + 4, 43 were 4 + 3. ADC ratio was significantly different between the two GP groups (p = 0.001). PI-RADSv2 score (''low'' vs. ''high'') was not significantly different between the two GP groups (p = 0.17). Regression analysis selected ADC T (p = 0.03) and ADC ratio (p = 0.0007) as best predictors to differentiate GP 4 + 3 from 3 + 4. Estimated sensitivity, specificity, and accuracy of the predictive model in differentiating GP 4 + 3 from 3 + 4 were 37, 82, and 66%, respectively. Conclusions: ADC metrics could differentiate GP 3 + 4 from 4 + 3 PCa with high specificity and moderate accuracy while PI-RADSv2, did not differentiate between these patterns.
ification [9, 10] . Acquisition of apparent diffusion coefficient (ADC) maps, derived from diffusion-weighted imaging (DWI), is recommended by the American College of Radiology as part of standardized mpMRI protocol, as it has been shown that adding DWI and ADC maps increases accuracy for PCa detection and localization [11, 12] . Quantitative metrics derived from ADC, including mean, median ADC, and ADC ratio (defined as the ratio of ADC values of tumor to normal tissue) have been shown to inversely correlate with GS, confirmed on RP specimens [13] [14] [15] . Among the various metrics, ADC ratio has been shown to correlate best with GS on RP [14, 16] . ADC ratio is also thought to overcome the variability of absolute ADC values related to both patient and technical factors (such as DWI b value) [16] [17] [18] In the heterogeneous GS = 7 PCa group, ADC metrics have been shown to be helpful in differentiating GP 3 + 4 from GP 4 + 3 PCa, with mean ADC and ADC entropy (a textural-based measure of the variation of the ADC values across the lesion) helpful in differentiating between these 2 patterns [19, 20] .
The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) is a qualitative MRI-based reporting system, which was first introduced 2012 by the European Society of Urogenital Radiology, and updated to its second version by a larger international group, whose aim is to standardize mpMRI acquisition, interpretation, and reporting [12, 21] . PI-RADSv2 utilizes a 5-point scale to determine the likelihood of clinically significant PCa, and is based upon qualitative interpretation of DWI/ ADC, dynamic contrast-enhanced MRI (DCE-MRI), and T2-weighted imaging (T2WI) [12] . PI-RADSv2 has shown to improve preoperative detection of clinically significant PCa, but there is scarce data regarding its predictive role in discriminating GP 3 + 4 from GP 4 + 3 PCa [12, 22] .
The aim of this study was to evaluate the predictive roles of qualitative PI-RADSv2 and quantitative ADC metrics (mean ADC and ADC ratio) in differentiating GP 3 + 4 PCa from the more aggressive 4 + 3 PCa, as defined on RP.
Materials and methods

Patients
This retrospective study was HIPAA compliant and approved by the local Institutional Review Board. Using our institutional search engine, we first queried cases with diagnosis of prostate cancer; who underwent multiparametric 3T prostate mpMRI from 2011 to 2015; and with history of RP. Of the retrieved cases, only treatment-naive GS = 7 either in the peripheral (PZ) or transitional zone (TZ) PCa cases were included in the study.
MRI technique
All MRI examinations were performed on a 3.0 T magnet (GE Signa HDx, GE Healthcare, Waukesha, WI) using an eight-channel abdominal array and endorectal coil (Medrad, Pittsburgh, PA), as previously described [23, 24] . Our protocol included spoiled gradient echo (SPGR) T1-weighted sequences with repetition time (TR)/echo time (TE)/a = 385 ms/6.2 ms/65°, over a 16-cm 2 field of view (FOV); fast relaxation fast spin echo (FRFSE) T2-weighted sequences with TR/TE = 3500 ms/102 ms over a 16-cm 2 FOV; single-shot echo planar (EPI) DWI sequences with TR/TE = 2500 ms/65 ms and TR/TE = 3000 ms/80 ms for 0,500 0,1400 s/mm 2 b values, respectively. In addition, 3D SPGR DCE sequences were acquired with TR/TE/a = 3.6 ms/1.3 ms/ 15°, with full-gland coverage, and image voxel size of 1 9 1 9 6 mm 3 , as previously described [25] . Temporal resolution was 5 s, for a total observation time of 5 min Gadopentetate dimeglumine (Magnevist, Berlex Laboratories, Wayne, NJ) was injected intravenously (0.15 mmol/kg) at 3 mL/s injection rate.
Clinical and histopathologic information collection
Subjects' age, serum prostate-specific antigen (PSA) at the time of diagnosis, date of prostate mpMRI, and date of RP were collected using our electronic medical records database. The histopathology reports of the RP specimens were reviewed, and primary and secondary GP were recorded. All RP specimens were processed according to the Stanford protocol [26, 27] .
Image analysis
A single radiologist (F.F.), with over 15 years of experience interpreting prostate MRI, reviewed the de-identified mpMRIs to identify the index lesion. The radiologist was aware of a diagnosis of PCa, age, and PSA levels, but was blinded to GS and GP. Tumor location (PZ or TZ) and highest DWI b value (500 or 1400 s/mm 2 ) were recorded. An overall PI-RADSv2 assessment score (based upon T2, DWI/ADC, and DCE) was assigned using PI-RADSv2 recommended algorithm (12) . A PI-RADSv2 score of 4 or 5 was defined as ''high risk,'' whereas a PI-RADSv2 score £ 3 was defined as ''low risk.'' All available MRI images for each case were viewed to identify the index tumor (T). After T was identified, Circular regions of interest (ROI) were drawn on ADC maps (b = 0,500, or b = 0,1400) on the index tumor (T), encompassing most of the lesion, and on the normal (N) prostatic tissue (an area of noncancerous tissue similar in size and in the same prostate zone of the T). T2-weighted, DCE, and DWI images were used as a reference when the index lesion was not visible on ADC maps. Mean ADC for T (ADC T ) and N (ADC N ) were calculated for each ROI. ADC ratio was defined as ADC T / ADC N .
Statistical analysis
Continuous variables were summarized using means and ranges, and categorical variables were summarized using frequencies and percentages. Independent sample t test, or Mann-Whitney test when data were not normally distributed, was used to compare ADC T and ADC ratio in the two groups (GP 3 + 4 vs. 4 + 3). Comparison between location on MRI (PZ vs. TZ), DWI b value (500 vs. 1400 s/mm 2 ), and PI-RADSv2 score was carried out with a v 2 or Fisher's exact test in the two groups.
Stepwise logistic regression analysis using location on MRI (PZ and TZ), ADC T , ADC ratio , b value (either 500 or 1400), and PI-RADSv2 score as predictors and GP 4 + 3 as response was performed. A two-tailed p value less than 0.05 was considered significant. All statistical analyses were performed using STATA (Version 11.2 StataCorp College Station, Texas USA).
Results
Patients and tumor characteristics
A total of 645 patients who had a prostate mpMRI and RP-confirmed PCa were identified from the initial query. We excluded patients who did not have an RP within a 6-month window of the mpMRI (n = 434), those with a GS £ 6 or ‡ 8 (n = 78), and those with no identifiable lesion on mpMRI (n = 9). 124 patients were initially retrieved. Those with diffuse PCa lesions encompassing the PZ and TZ (n = 1), lesions located in the central zone (n = 3) or in the anterior fibromuscular stroma (n = 1) were excluded. Our final population consisted of 119 patients with a PZ-or TZ-dominant lesion (Figs. 1,  2) .
Tumor characteristics are reported in Table 1 . Of the 119 lesions, 76 lesions were GP 3 + 4 and 43 were GP 4 + 3. Mean age was 59.48 years (range 43-76 years) and mean PSA was 7.29 ng/ml (range 1.64-38.7).
MRI analysis
MRI characteristics of the included cases are also reported in Table 1 . Of the 119 identifiable PCa lesions, 99 were located in the PZ and 20 were located in the TZ. Tumor location on MRI (PZ vs. TZ) did not differ between the two GP groups (p = 0.693).
ADC and b value
Fifty-one mpMRIs were performed with highest DWI b value of 500 s/mm 2 
PI-RADSv2
A total of 110 lesions were categorized as ''high'' PIRADSv2 score (PI-RADSv2 score ‡ 4). Of these, 68 lesions were PI-RADSv2 score 4 and 32 were PAC 5. Regarding tumor location, 60 PZ lesions were categorized as PI-RADSv2 score 4 and 32 PZ lesions were PAC 5, whereas 8 TZ lesions were categorized as PI-RADSv2 score 4 and 10 were categorized as PI-RADSv2 score 5. Regarding GP groups, 46 3 + 4 GP lesions were PIRADSv2 score 4, 22 were PI-RADSv2 score 5, whereas 23 4 + 3 GP lesions were PI-RADSv2 score 4, and 19 were PI-RADSv2 score 5. There was no significant association between ''high'' PI-RADSv2 score and 4 + 3 PCa (0.485). When only ''high'' PI-RADSv2 score lesions were considered, no significant difference between PI-RADSv2 score 4 or 5 assigned between the two GP groups was observed (p = 0.174).
Logistic regression analysis and predictive model
Logistic regression was performed with GP = 4 + 3 as response, and location, ADC T and ADC ratio , b value, and PI-RADSv2 score as predictors. Cases with PIRADSv2 score < 4 were excluded from analysis, and a total of 110 cases were included in the model. A stepwise regression starting with the full model and minimizing AIC (Akaike Information Criterion) resulted in the selection of a model which included only ADC T and ADC ratio (p = 0.04 and 0.002, respectively, AIC = 139.1). Thresholding the fitted values from this regression at 0.5, the estimated sensitivity of the predictive model in differentiating GP 4 + 3 from 3 + 4 PCa was 37%, specificity 83%, and accuracy 65%. Including 5 PIRADSv2 score = 3 cases did not significantly change the results, and only ADC T and ADC ratio were selected in the model (p = 0.03 and 0.0007, respectively, AIC = 149). Estimated sensitivity of the model was 40%, specificity 82%, and accuracy 67%. When all 119 cases were included, only ADC T and ADC ratio were selected (p = 0.0359 and 0.0004, respectively) resulting in a model with estimated sensitivity of 37%, specificity of 82%, and accuracy of 65%.
Discussion
Gleason 7 PCa represents a heterogeneous population of PCa comprising GP 3 + 4 and GP 4 + 3 lesions with different recurrence rate, prognosis, and treatment [7] . In this study, we showed that quantitative ADC T and ADC ratio predict differentiation between GP 3 + 4 and 4 + 3 PCa, with an accuracy of 67%. In our population, we could not demonstrate a role for PI-RADSv2 in predicting GS = 7 PCa subtype. In addition, we demonstrated that ADC ratio was significantly different between the two GP 3 + 4 and 4 + 3 PCa, whereas no significant difference in the ADC T was observed between the two groups.
The role of ADC metrics in differentiating GP 3 + 4 vs. 4 + 3 PCa has been addressed by few studies [19, 20, 28] . A study on 57 GS = 7 PCa showed that ADC/T2 ratio, defined as the ratio of ADC values and of the signal intensity of the tumor measured, respectively, on ADC maps and T2WI, had a sensitivity of 77.5% and a specificity of 64.7% in discriminating GP 3 + 4 from 4 + 3 PCa [29] . In our study, a predictive model comprising only ADC T and ADC ratio to differentiate GP 4 + 3 from 3 + 4 PCa, showed sensitivity of 37%, specificity of 83%, and accuracy 65%, when cases with PI-RADSv2 score ‡ 4 were included. Our comparatively low sensitivity may be explained by the fact that our population was composed solely of GS = 7, and differentiation between GP 3 + 4 and 4 + 3 may be more challenging that differentiation of GS = 7 from GS 6 or 8.
We found that ADC T was not significantly different between GP 3 + 4 and GP 4 + 3 PCa. These findings are discordant with a study that correlated ADC and GP [20] . In this study of 37 patients with GS = 7 PCa, mean ADC was significantly different between GP 3 + 4 and GP 4 + 3 [20] . In the study by Itou et al., all cases were obtained with b values of 0,1000 s/mm 2 , and absolute ADC values, including mean ADC T , are dependent on the b value selected [17, 20] . It is possible that the difference might be explained by the different b values used in the two studies, as ADC was obtained in 51 of our cases using b values of 0,500 s/mm 2 and using 0,1400 s/ mm 2 in 68 cases. Interestingly, a more recent study on 84 hypointense non-circumscribed lesion, measured < 1.5 cm in greatest dimension confined to prostate (white arrowhead), corresponding to a T2 W score of 3 according to PI-RADS v2. Dynamic contrast-enhanced (DCE) image showed no corresponding focal or early enhancement, and a negative DCE score was assigned (D). A PI-RADS v2 score of 4 was assigned to the lesion. The mean ADC mean of the lesion was 945 and the ADC ratio was 0.76 (B). GS = 7 PCa showed no significant difference in mean ADC of GP 3 + 4 vs. 4 + 3 Pca [19] . Another study evaluated mean ADC in 21 GS = 7 PCa, showing no significant difference the two GP groups [29] .
Regarding ADC ratio , various studies have addressed the role of this ADC metric in differentiating PCa with different GS [14, 16] . A recent study on 45 PCa patient, 21 of which were GS = 7, showed significant difference in ADC ratio in differentiating GP 3 + 4 and 4 + 3 lesions [29] . De Cobelli et al., showed that ADC ratio could differentiate between GS 6, 7, and 8-10 PCa; however, no data regarding differentiation between different GP 3 + 4 and 4 + 3 PCa were presented [14] . Woo et al. evaluated the role of various ADC ratio in differentiating GS = 6 from GS ‡ 7 PCa, yet no data regarding the predictive role of ADC ratio in differentiating GP 3 + 4 and 4 + 3 lesions were reported [14, 16] .
Our results, showing that only ADC ratio was significantly different between GP 3 + 4 and 4 + 3 PCa, reflect the data reported in literature, as few studies comparing ADC and ADC ratio found that the latter was superior to mean ADC in determining aggressive PCa, including a study on 21 GS 7 PCa patients who showed that ADC ratio was significantly different, while mean ADC was not significantly different [15, [29] [30] [31] . Nonetheless other data suggest similar performance of mean ADC and ADC ratio in determining aggressive PCa [14] . Our results may be explained by the fact that ADC ratio is relatively independent of the b value used, whereas absolute ADC values depend on the b value selected [17] .
Regarding the predictive role of PI-RADSv2, we found no role for PI-RADSv2 in differentiating GP 3 + 4 vs. 4 + 3 PCa. In addition, no association between GP and PAC was observed. A prior study on 425 PCa evaluated the role of PI-RADS to predict clinically significant PCa [22] . Although 250 GS = 7 PCa cases were included in the analysis, no analysis of the role of PI-RADSv2 in differentiating GP 3 + 4 vs. 4 + 3 PCa was performed [22] .
Our study has several limitations. First, it is a retrospective study. Although the radiologist was blinded to the GS, the evaluation of a predictive role of a diagnostic test is inherently limited, given the study type. In addition, retrospective studies rely on others for accurate recordkeeping and some biases such as selection bias and misclassification or information bias can negatively impact the veracity of this type of study. Furthermore, we used different b values for DWI, and not all cases were performed with b value of 1400 s/mm 2 . Specifically, more than one-third of mpMRI, performed before PIRADSv2 recommendation for the use of high b value was available, had highest b value of 500 s/mm 2 [12] . Although both GP groups had the same proportion of mpMRI performed with low b value, this might have reduced the performance of ADC T and the diagnostic performance of PI-RADSv2 [12, 32] . Nonetheless, various studies showed that mean ADC was significantly different for GP £ 3+4 vs. GP ‡ 4+3 PCa, even when acquired on DWI with b values < 1000 mm/s 2 [33] [34] [35] . Lastly, mpMRI were analyzed by a single reader, who however had over 15 years of experience in interpreting prostate MRI. Inter-reader agreement was not evaluated. However, a recent study evaluated inter-reader agreement of PI-RADS v2 for detection of GP ‡ 3+4 PZ PCa, showing almost perfect agreement (k > 0.9) [36] .
In conclusion, our findings suggest that quantitative ADC metrics can predict differentiation between GP 3 + 4 and 4 + 3 PCa, with acceptable accuracy, whereas PI-RADSv2 did not have a predictive role.
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